Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol.
about
Imaging methods for the local lymphatic system of the axilla in early breast cancer in patients qualified for sentinel lymph node biopsyBiphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy.Complications of methylene blue dye in breast surgery: case reports and review of the literature.Cardiac Arrest after Patent Blue V Injection for Sentinel Lymph Node Biopsy in Breast Cancer.Peri-operative anaphylaxis.Does blue dye contribute to success of sentinel node mapping for breast cancer?A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.Breast cancer and pregnancy: current concepts in diagnosis and treatment.Contraindications of sentinel lymph node biopsy: are there any really?Adverse reaction; patent blue turning patient blue.Dyed but not dead.Adverse drug reaction, patent blue V dye and anaesthesiaSentinel lymph node biopsy for breast cancer: current controversies.Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis.Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery.Hypersensitivity reactions to Patent Blue V in breast cancer surgery: a prospective multicentre study.Sentinel lymph node biopsy for melanoma in pregnant women.The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.Patent blue dye and an atypical anaphylactic reaction after sentinel lymph node biopsy in early breast cancer.Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?
P2860
Q26751906-4071F547-94D6-4C2C-B16A-A30D354A76A0Q30491034-DF4850BD-C0F8-456A-A07E-245C90099D29Q34422516-3D64CC1D-741E-4AC4-AA67-B8094944E0DCQ34791161-D6F160BF-28AD-4666-AB19-E648F47447C8Q34976458-18AD9509-7113-4BD9-BA6B-14D0366BB5B1Q35125043-E249788D-4A13-483D-BC56-7BA37031B888Q35525245-D068E2D9-3B79-425E-9658-F543E624B5A2Q35583829-1FFEBB1C-AACA-4ECB-8635-9F7D006E0BD1Q35634145-0B77A8C8-14A5-4BD1-9F43-8FB5DC674623Q35980454-A351CDA7-6559-4195-A2B6-7CDE33E6B86CQ36071044-492EB9C7-C2BA-449D-A858-08589DDC0FE4Q36536887-7D915F22-1B2C-48E2-A10B-5E2263F5D92BQ36588406-348F74E9-76FA-4974-A1A6-D0197775C294Q39985350-3546D449-6C2C-426F-B566-6BEC4F5F38A6Q41632703-26E68935-2D0F-446F-951B-BB8746471D84Q43422491-3F8E4612-ADF5-454E-B1E3-C3132B4FD7A7Q44332123-BD652E4C-002A-47EA-8911-0F2ED1510F94Q44661227-516733CA-1129-41C6-BFC5-EA26F1E1320BQ50265599-8EDE4F9F-614C-444A-9900-31E207CF5997Q50476024-4DD0B74A-ADA9-4B1A-9A79-0E85E659A0C2
P2860
Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Incidence of anaphylactoid rea ...... ve clinical practice protocol.
@en
Incidence of anaphylactoid rea ...... ve clinical practice protocol.
@nl
type
label
Incidence of anaphylactoid rea ...... ve clinical practice protocol.
@en
Incidence of anaphylactoid rea ...... ve clinical practice protocol.
@nl
prefLabel
Incidence of anaphylactoid rea ...... ve clinical practice protocol.
@en
Incidence of anaphylactoid rea ...... ve clinical practice protocol.
@nl
P2093
P356
P1433
P1476
Incidence of anaphylactoid rea ...... ve clinical practice protocol.
@en
P2093
Barry W Feig
Chandrajit P Raut
Frederick C Ames
Gailen D Marshall
Gildy Babiera
Henry M Kuerer
Jeri S Akins
Kelly K Hunt
M Denise Daley
Merrick I Ross
P2860
P304
P356
10.1002/CNCR.21226
P407
P577
2005-08-01T00:00:00Z